Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.
about
Nutritional manipulation of one-carbon metabolism: effects on arsenic methylation and toxicityGut microbiome perturbations induced by bacterial infection affect arsenic biotransformationArsenite selectively inhibits mouse bone marrow lymphoid progenitor cell development in vivo and in vitro and suppresses humoral immunity in vivoRenal function is associated with indicators of arsenic methylation capacity in Bangladeshi adultsDeterminants and Consequences of Arsenic Metabolism Efficiency among 4,794 Individuals: Demographics, Lifestyle, Genetics, and ToxicityArsenic exposure and toxicology: a historical perspectiveDifferential methylation of the arsenic (III) methyltransferase promoter according to arsenic exposureArsenic Exposure and Type 2 Diabetes: MicroRNAs as Mechanistic Links?Influence of cobalamin on arsenic metabolism in BangladeshAS3MT-mediated tolerance to arsenic evolved by multiple independent horizontal gene transfers from bacteria to eukaryotes.Metabolism, toxicity and anticancer activities of arsenic compounds.Interspecies differences in metabolism of arsenic by cultured primary hepatocytesArsenic (+ 3 oxidation state) methyltransferase and the methylation of arsenicals in the invertebrate chordate Ciona intestinalis.Polymorphisms in arsenic(+III oxidation state) methyltransferase (AS3MT) predict gene expression of AS3MT as well as arsenic metabolism.Evaluation of the carcinogenicity of inorganic arsenic.Human adaptation to arsenic-rich environments.An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis.Creatinine, arsenic metabolism, and renal function in an arsenic-exposed population in BangladeshArsenic immunotoxicity: a review.A transgenic Drosophila model for arsenic methylation suggests a metabolic rationale for differential dose-dependent toxicity endpoints.Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicityRegulation of iNOS function and cellular redox state by macrophage Gch1 reveals specific requirements for tetrahydrobiopterin in NRF2 activation.Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acidMathematical model insights into arsenic detoxificationArsenic toxicology: translating between experimental models and human pathology.Identification of Small Molecule Inhibitors of Human As(III) S-Adenosylmethionine Methyltransferase (AS3MT)Interactive Effects of N6AMT1 and As3MT in Arsenic Biomethylation.Identification of an S-adenosylmethionine (SAM) dependent arsenic methyltransferase in Danio rerio.High-throughput screening-compatible assays of As(III) S-adenosylmethionine methyltransferase activity.Altered arsenic disposition in experimental nonalcoholic fatty liver disease.Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradationBiological and behavioral factors modify urinary arsenic metabolic profiles in a U.S. population.N-6-adenine-specific DNA methyltransferase 1 (N6AMT1) polymorphisms and arsenic methylation in Andean womenAnalysis of maternal polymorphisms in arsenic (+3 oxidation state)-methyltransferase AS3MT and fetal sex in relation to arsenic metabolism and infant birth outcomes: Implications for risk analysisBody composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study.Requirement of arsenic biomethylation for oxidative DNA damage.Oxidation state specific analysis of arsenic species in tissues of wild-type and arsenic (+3 oxidation state) methyltransferase-knockout mice.Linking selenium biogeochemistry to the sulfur-dependent biological detoxification of arsenic.Metabolism of arsenic and its toxicological relevance.Natural Antioxidants Against Arsenic-Induced Genotoxicity.
P2860
Q28382946-9AF1E79D-0059-4157-8E21-85DE8FAF3F50Q28383247-E6254185-C78C-4547-BE69-7C00637E412CQ28383651-7D15BF0E-D8BA-44E7-971C-E89C3F316808Q28385894-C915090E-7CD9-4609-B5F0-3F63C1349DA6Q28388011-D298FB91-015D-475D-920D-7ABD3DAB2334Q28392204-078BF2F2-960A-4618-8236-6EEB4A7A162BQ28397251-15E917CD-BF9F-4463-87AE-52C30E65FB6CQ29248177-42593C12-5E91-4D3A-A593-5491501F71EAQ33569457-B6BF2392-ADCA-4DD6-A3F0-1383CF4C0D70Q33584549-745075C4-47F4-4287-A77A-189B955F0C1FQ33618916-923E6254-4287-409E-9B13-4BEDCB3FE9F6Q33823587-09DC6B2D-3905-4A3C-98F8-FBFCD01CBA08Q33988886-DCA546FB-F7CA-4700-84A9-F71EA5ADAE18Q34159791-571F4447-193B-4699-A847-D3888BD8DF47Q34371580-1545BACE-8E95-4810-A828-658967ACB849Q34465718-C3788F1B-A0CE-4A01-90F3-92F240BDECD7Q34478447-949B9998-C3C1-4C18-ADF9-95FACE5D9EC8Q34599799-EDF5BDED-3EAA-47A8-BDB2-723076E8443DQ34655901-3AA5B5B9-B505-4969-B967-E995AE53E345Q34995682-3A5D5B6A-EE92-44B8-9E5D-76B764FD7215Q35044729-B3CAD8E3-158A-4E9A-8666-88E629EC867CQ35130170-E4AD61B5-B61C-4A4B-9304-289AADBB5233Q35291485-5581EA6F-43D8-448D-BBBA-C9D3AD37504DQ35574373-AAE3AA63-47A1-4EC0-8A3D-A29707D65602Q35591935-D69C8F60-3213-43D3-B9FD-B6E149D96FDBQ35844220-AB5C1F08-0254-4419-92DC-F5A6B25DA6C2Q35975233-8925EBF5-BD2F-479E-8CF5-5A86818B44BFQ36088753-206F0D02-92B9-4AC1-9A03-FC514CA5D340Q36089643-89C3356B-4448-483C-BCE6-81B511753F5EQ36174255-6B0C8BBB-22D1-417C-B869-92BAF246BA54Q36413252-74DC6387-6D22-4AFD-98E7-16D92048A871Q36937175-EB18DEED-7679-4B95-9215-644B12A2C4BFQ36984093-3E9F26D2-124A-4D16-BAE1-192657D12803Q37146092-2B4A2128-37CA-4480-9A49-4E907BB05323Q37444401-E2D0713D-D901-404C-9C93-1BACC37647BAQ37478021-E989914F-6913-4979-A6FD-2383017BAAB1Q37725102-BA23E106-26E1-4F4E-A209-540E37DD4DB5Q38003650-A1A31599-7087-44B0-B42F-7E0CE3521A89Q38027433-3906671E-37FD-41E2-8A0B-B275D78A2B76Q38560781-5A96E58B-BF58-432A-9934-A9A12EC4AD92
P2860
Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disruption of the arsenic (+3 ...... orally administered arsenate.
@en
Disruption of the arsenic
@nl
type
label
Disruption of the arsenic (+3 ...... orally administered arsenate.
@en
Disruption of the arsenic
@nl
prefLabel
Disruption of the arsenic (+3 ...... orally administered arsenate.
@en
Disruption of the arsenic
@nl
P2093
P2860
P356
P1476
Disruption of the arsenic (+3 ...... f orally administered arsenate
@en
P2093
Brenda C Edwards
David J Thomas
John T Creed
Karen Herbin-Davis
Kevin M Kubachka
Michael F Hughes
Miroslav Styblo
Noboyu Maeda
Zuzana Drobna
P2860
P304
P356
10.1021/TX900179R
P577
2009-10-01T00:00:00Z